Member Info for Fruitsnveg

I think so. I think it says the likes of Synairgen have lessons for future pandemics. It must be thought that they will be here again, for the next one, and the one after that, etc.

I think there should be a recording, or highlights, there usually is.

Breatheasy
Well written post. 2 things stand out - the notion of a placement. Are there more that 1 ways to peel an apple? There are indeed. Alternative financing methods work also. A bit of research shows me some sponsors at events are in such areas. So, IMO, talk of placements are immature and possibly off the mark.
2nd point - price. It is very difficult to pin a price without referring to the BOD who after all know best. I’m reading of the tax regulations between the US and UK make it such that non-American pharmacy selling drug into the US do so at a more advantageous price point than an American pharma can do ( a point of pain for American pharmas). That could have an impact, so hanging a $2k or $3k price on SNG001 at this point risks getting it quite wrong. Scale is another very important pricing element. So I simply urge caution when figures are thrown out there as there are many cogs to this wheel. Just my thoughts.

“Categorically” .
I’m intrigued by your absolute devotion to that notion CityT. Do you have further insight?

Evening all,
Those wishing to get the booster vax should try booking online (nhs.uk). It seems the 6month+1week requirement since 2nd vax is being relaxed (official ststement to follow?). Booking systems seem to already be updated in readiness.
Please, no pro/anti vax responses - this is just for info for those that are waiting.

Pathetic.

Amazing. Well done those staff.

I would assume so Titania. All data counts.

Agree, succinctly said Matml.

'is of little importance', I meant.

Fortunatley, those who are suffering Covid fatigue are not those that are charged with striking deals to ensure global supplies. The II's are well researched, whether Joe/Joanna public are is not of little importance from here on in.

Jedi, I saw the same spike, it flashed upon my screen a short while ago. No idea what / how as it lasted a second - refreshed screen and gone. Definitely saw the 198 - snorted coffee out my nose so yeah, I remember :-). Very weird.

Thanks for noting those real-life EAU timeframes here Matml74, for the benefit of other investors.

Real life examples in recent months are far more weighty than partial anonymous messages from random people. Hopefully that has set your mind at ease Dan, it certainly has mine.

JW202, it makes sense if you consider negotiations are probably in progress (it would be naive to think otherwise given the timeframes involved in such manoeuvres). The big money now have majority stake here, not PI's. It's in the interests of those holding majority stakes to keep the SP where it is, for now, so IMHO it is wholly unsurprising. I actually view it as a good signal, but wholly my own view. DYOR.

Dan
- who is Bill - role/organization?
- EAU in USA or EU, which trial is this referring to?
- where's the rest of the 'message'. I assume he didn't start his reply with 'For other therapeutics', which would be nonsense.

https://www.theguardian.com/world/2021/nov/11/us-covid-wildlife-virus

"with troubling implications for eradicating the virus and potentially even for the emergence of new variants."

"Nearly everything about their study shocked the scientists. They knew deer could be infected with the coronavirus. But they were stunned by the numbers – four out of five deer tested positive at the highest peak – as well as high viral loads that were “truly gobsmacking”, Suresh Kuchipudi, clinical professor of virology at Penn State and co-author of the study"

I know we are in the business end now, but studies like this show it's going to be an uphill battle, even if every person on the planet were vaccinated.

Interesting. What kind of a nebuliser were you using during your studies Sakura?
I note you side-stepped my earlier question on your thoughts on Ribavirin, given that it was you who raised the treatment of Hepatitis in the 80's. Your response was that you hadn't looked at the data. As a scientist involved in research you would know this.
Perplexed.

A corporate announcement between now and P3 would not surprise me. Polygon have been moving fast. With weeks still to go, I can only think there's a reason for their haste.

It depends on the provisions in place Ndn17. Also a TO isn't inevitable. Biontech set a new standard, their 'collaboration' with Pfizer is arguably a shining positive new model example in the M&A space that I can see being adopted by big players. Faster to execute and it benefits more parties, not least, patients. But who knows.

JSP123. AZ already has DD on Synairgen (2016). If there's another party or parties (even better), they will already have been doing DD, for some time. They wouldn't wait until after P3 to roll up and ask to look at the books and inspect the cooks. The SP price pattern, along with a few other things, tells me this has been in play for a while. But that's my view, each follow your own take and act accordingly.